Multimodal imaging outcome measures for ALS (Image ALS)

Multimodal imaging outcome measures for ALS (Image ALS)

Multimodal imaging outcome measures for ALS (Image ALS)

Recruiting
18-90 years
All
Phase 1
  • Simplified description (AI rewritten)
  • Technical description (Original)
The purpose of this study is to study a new radioactive tracer, a type of imaging drug that is labeled with a radioactive tag and injected into the body to see how it is taken up in the brain using an imaging procedure called Positron Emission Tomography (PET/CT).  We will use two different kinds of radioactive tracers in this study, 11C-PBR28 and 18F-Fluorodeoxyglucose ([18F]-FDG). We want to know if these radiotracer images can be used in future clinical treatment trials to assess disease progress and how well treatments are working.
 
11C-PBR28 is an investigational or experimental imaging agent that has not yet been approved by the Food and Drug Administration (FDA) for use in humans. The purpose of this study is to test whether 11C-PBR28 binds to a receptor in the brain called a peripheral benzodiazepine receptor (PBR) as a measure of local inflammation and if there are any changes in this binding in repeat scans.
[18F]-FDG is an FDA approved tracer for imaging of the brain and body. We will use the [18F]-FDG uptake as a measure of how sugar is taken up and metabolized in areas of the brain and compare these images to the 11C-PBR28 images.
 
The scans you receive for this research study will not be used for clinical care. This means that your doctors will not use the PET/CT information from this study for your medical care.

You will also be asked to undergo brain MRI scans for this study and will sign a separate consent for the MRI. PET/CT and MRI images will be compared to evaluate changes in the brain over time. You must be in the MRI part of this study to take part in the PET/CT scans for the study.  If you have questions about the MRIs please ask the research staff.
 
The 11C-PBR28 and[18F]- FDG PET/CT scans will be done on the same day as the baseline and 6-month MRI imaging session. You will be asked to undergo an additional 3-month PET/CT imaging session during the study.
There will be one group of patients in this study that will include patients with amyotrophic lateral sclerosis (ALS).
Print
Study details
    ALS
    healthy

TBD

19 February 2024

Contact a study center
Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Please provide your preferred way of contact
Race
Select race
Ethnicity
Select ethnicity
Other language

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.